Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories ...

FDA Drug Recall #D-1492-2020 — Class II — July 14, 2020

Recall Summary

Recall Number D-1492-2020
Classification Class II — Moderate risk
Date Initiated July 14, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Teva Pharmaceuticals USA
Location Parsippany, NJ
Product Type Drugs
Quantity 28,596 cartons

Product Description

Lidocaine Patch 5%, packaged in 30-count cartons, Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-3525-30

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.

Distribution Pattern

Nationwide United States

Lot / Code Information

Carton Lot # 1383513B, Patch Lot # 1383513, Exp date 03/2022

Other Recalls from Teva Pharmaceuticals USA

Recall # Classification Product Date
D-0461-2022 Class II Doxylamine Succinate and Pyridoxine Hydrochlori... Jan 18, 2022
D-0520-2022 Class II Tretinoin Capsules, 10 mg, 100 count bottle, Rx... Jan 10, 2022
D-0522-2022 Class III Mimvey (estradiol and norethindrone acetate tab... Jan 7, 2022
D-0521-2022 Class III Mimvey (estradiol and norethindrone acetate tab... Jan 7, 2022
D-0370-2022 Class II MethylPREDNISolone Acetate Injectable Suspensio... Dec 31, 2021

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.